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Abstract
Background: The BDNF gene codes for brain-derived neurotrophic factor, a growth factor involved in neural
development, cell differentiation, and synaptic plasticity. Present in both the brain and periphery, BDNF plays critical
roles throughout the body and is essential for placental and fetal development. Rodent studies show that early life
stress, including prenatal stress, broadly alters BDNF methylation, with presumed changes in gene expression. No studies
have assessed prenatal exposure to maternal traumatic stress and BDNF methylation in humans. This study examined
associations of prenatal exposure to maternal stress and BDNF methylation at CpG sites across the BDNF gene.
Results: Among 24 mothers and newborns in the eastern Democratic Republic of Congo, a region with extreme
conflict and violence to women, maternal experiences of war trauma and chronic stress were associated with BDNF
methylation in umbilical cord blood, placental tissue, and maternal venous blood. Associations of maternal stress and
BDNF methylation showed high tissue specificity. The majority of significant associations were observed in putative
transcription factor binding regions.
Conclusions: This is the first study in humans to examine BDNF methylation in relation to prenatal exposure to
maternal stress in three tissues simultaneously and the first in any mammalian species to report associations of prenatal
stress and BDNF methylation in placental tissue. The findings add to the growing body of evidence highlighting the
importance of considering epigenetic effects when examining the impacts of trauma and stress, not only for adults but
also for offspring exposed via effects transmitted before birth.
Keywords: Brain-derived neurotrophic factor, BDNF, Stress, Trauma, War, Prenatal, DNA methylation, Transcription
factor, Blood, Placenta
Background
Throughout life, brain-derived neurotrophic factor
(BDNF) acts as a key regulator of neuronal development
and activity including axonal growth, maturation and
survival of neurons, and synaptic plasticity [1]. This
neuronal growth factor, encoded by the gene BDNF, is a
member of the neurotrophin family of polypeptide
growth factors that are widely expressed throughout the
brain and impact a broad range of brain functions [2, 3].
BDNF crosses the blood-brain barrier and is present in
the bloodstream and peripheral tissues as well, exerting
neuro-protective effects throughout the body [4–6].
During the prenatal period, BDNF potentiates placental
development and facilitates cytotrophoblast differenti-
ation, proliferation, migration, and survival necessary for
fetal growth [7, 8].
The structure and sequence of the BDNF gene is com-
plex but highly conserved across species [9]. In humans, it
contains 11 exons, nine of which contain promoters that
regulate its expression [10]. Regulation of BDNF is also
tightly controlled by multiple transcription factors and by
intracellular signaling pathways that involve binding to
specific receptors [11]. To add to the complexity, exons
and transcripts vary in their expression across neural
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structures and other tissues, and across development both
pre- and postnatally [12].
BDNF has widespread functional consequences for
development. Rodent studies implicate BDNF expression
in learning and memory, aggressiveness, anxiety-like
behavior, and fear memory formation and consolidation
[13–16]. In humans, BDNF levels are altered in atten-
tional, neurodevelopmental, and stress-related mood and
anxiety disorders [17–21]. At birth, higher maternal
blood but lower cord blood and placental BDNF levels
are associated with prematurity and lower gestational
age [22–26], with cord blood levels also predicting birth
complications [27, 28].
Bidirectional influences between BDNF levels and the
stress-sensitive hypothalamic-pituitary-adrenocortical
(HPA) axis implicate a role for stress in BDNF signaling.
Elevated levels of glucocorticoids, released from the
HPA axis following stress, interfere with BDNF signaling
[29]; at the same time, BDNF and glucocorticoids co-
regulate activation of the HPA axis [30].
Robust evidence for stress-induced changes in behavior
and BDNF levels in several brain regions comes from ani-
mal models [31–33] of experimental stress administered
to mothers before or during pregnancy and in the early
postnatal period [34–37]. Animal models also show that
early life stress exposure induces changes in BDNF methy-
lation, though the direction of effects varied by develop-
mental timing of exposure, age at testing, tissue source,
and BDNF loci tested [35, 38–42]. Stress-induced epigen-
etic changes at the exon IV promotor are the most widely
reported, although effects have been observed across the
BDNF gene. Interestingly, stress-induced epigenetic
modifications to BDNF can be transmitted intergenera-
tionally and are not reversed by cross-fostering, suggesting
they occur prenatally during exposure to the intrauterine
environment [43].
Less is known about the effects of stress exposure on
BDNF methylation in humans. Among adults, BDNF
methylation levels in blood or saliva are associated with
anxiety, major depressive disorder, post-traumatic stress
disorder, and a history of childhood maltreatment or
exposure to domestic violence [44–49]. In two studies of
psychiatric patients, a history of childhood maltreatment
was associated with methylation in sites homologous to
genomic regions identified in rodent studies in exons 1
and 4 [44, 45]. In exon 4, associations were observed al-
most exclusively at putative transcription factor binding
(TFB) sites with important regulatory control over gene
expression [45].
Only two studies have investigated BDNF methylation
in relation to prenatal emotional state, both of which ex-
amined maternal depressive symptoms with methylation
levels quantified at the exon 4 promotor. In one study,
no relation of depressed mood to BDNF methylation
was observed in neonatal cord blood [50]. In the other,
exposure to prenatal depressive symptoms significantly
predicted decreased methylation of BDNF in buccal cells
at 2 months of age [51].
To date, there are no published reports examining pre-
natal exposure to maternal traumatic stress and BDNF
gene methylation in humans. Moreover, despite know-
ledge that BDNF plays a key role in regulating placental
and fetal development [7, 52], there are no reports, ei-
ther human or animal, testing prenatal stress exposures
and BDNF methylation in placenta. The present study
addresses these gaps by examining prenatal exposure to
maternal psychosocial stress among mothers and new-
borns in a war-torn region of the eastern Democratic
Republic of Congo. The Congo has experienced military
and civilian conflict for more than two decades and is
routinely described as the site of one of the world’s worst
humanitarian crises [53]. Sexual violence and other acts
of terror, aggression, and human rights violations are
widespread and often co-occur with chronic social in-
equity and economic strain [54–56]. We have previously
documented in this population associations of war
trauma and chronic stress with DNA methylation in
genes regulating the HPA axis [57, 58].
Here, we report findings suggesting that maternal
experiences of war trauma and chronic stress are related
to DNA methylation levels across the BDNF gene in ma-
ternal blood, umbilical cord blood, and placental tissue.
In placenta, we also conducted targeted sequencing of
the BDNF exon 4 promotor, based on prior research in
rodent brain and human blood samples [11, 35], to
determine whether stress-linked epigenetic alterations
could be detected. We predicted that prenatal exposure
to maternal stress would be associated with BDNF
methylation in both newborn and maternal tissues.
Because of the complexity of the BDNF gene and evi-
dence from animal models that the direction of effects
vary by tissue source and gene locus [41, 59], directional
hypotheses regarding hypo- or hypermethylation in each
tissue were not posited. Based on our findings with
genes regulating the HPA axis [57], we expected war
traumas, due to their severity, would be a stronger pre-
dictor of DNA methylation than chronic stress. Based
on the high degree of conservation across species of
BDNF regions functionally relevant for gene transcrip-
tion [9], we highlight stress—methylation associations
for CpG sites situated at putative transcription factor
binding regions.
Results
We examined methylation levels at 67 CpG sites across
the BDNF gene via the HumanMethylation450 BeadChip
in maternal venous blood, umbilical cord blood, and
placental tissues. Analyses were conducted using beta
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regression such that positive regression coefficients
reflected higher methylation associated with higher
stress, whereas a negative regression coefficient was
indicative of lower methylation associated with higher
stress. The results showed that a total of 23 CpG sites
were significantly associated with chronic stress or war
trauma in one or more tissues at p < .05 (Table 1). A
total of 20 sites were associated with war trauma and
nine with chronic stress. Of those, six sites were pre-
dicted by both stressors (Table 1, italicized sites).
Twelve sites survived false discovery rate (FDR) cor-
rection with moderate confidence (q < .25); 11 with
war trauma and one with both war trauma and
chronic stress. For nominally significant sites (p < .05),
findings were considered meaningful and thus de-
scribed here if at least one of the following two a
priori criteria were met: previous association of the
CpG with traumatic stress or brain and behavioral
functioning, or situated at known or putative TFBs
[57] (indicated in Table 1). The results indicated that
all of the CpG sites with a prior history of association
in human or animal studies were situated at TFBs.
Locations of CpG sites situated at or near TFBs are
shown in Fig. 1. TFB region information is available
in Additional file 1: Table S1.
War trauma predicted methylation at 16 sites, explai-
ning 12–34% of the variance as indicated by R2 values
(Table 1). Chronic stress predicted methylation at six
sites, explaining 13–26% of the variance. Significant as-
sociations were observed in all three tissue types for
both stressors. Methylation correlations among each pair
of tissues were computed; none of the CpG sites in
Table 1 had significant cross-tissue correlations.
Methylation levels at nine CpG sites were associated
with war trauma in maternal blood: cg2429411,
cg16257091, cg04106006, cg06684850, cg12448003,
cg25412831, cg26949694, cg118067262, and cg05189570,
all of which survived FDR correction at moderate confi-
dence (q range = .05–.17; Table 1). Of the nine signifi-
cant sites, five were also located at putative binding
regions of one or more transcription factors: cg2429411,
cg16257091, cg06684850, cg12448003, and cg26949694,
with cg16257091 also previously identified in the litera-
ture (TFBs and citations shown in Table 1). Methylation
at cg04106006 and cg06684850 was also nominally asso-
ciated with chronic stress.
In placenta, methylation at cg10558494, cg15313332,
and cg25962210 was significantly associated with war
trauma after FDR correction (Table 1). cg25962210 was
located at a TFB and also nominally associated with
chronic stress. Several additional sites did not survive
FDR correction but were all situated within one or more
TFBs. These were cg16257091, cg28640770, and
cg27193031, associated with war trauma, cg26949694,
associated with chronic stress, and cg09492354, associ-
ated with both stressor types. cg26840770 has been pre-
viously identified in animal models and human studies
(see Table 1).
In cord blood, methylation at two CpG sites was
significantly associated with stressors after FDR cor-
rection: cg17413943 with war trauma and cg16257091
with chronic stress. The latter was the only CpG site
associated with chronic stress at FDR-corrected
significance. Three additional CpG sites were nomi-
nally significant but located at multiple putative TFBs:
cg01225698, cg09492354, and cg07704699, with
cg01225698 also showing prior association with
traumatic stress.
Most significant associations were tissue specific.
There were three CpG sites significant in more than one
tissue (cg16257091, cg26949694, and cg09492354). In all
cases, the direction of effect differed across tissues. At
cg16257091, higher maternal stress was associated with
lower methylation in maternal blood but higher
methylation in placenta and cord blood. Similarly, higher
maternal stress was associated with lower methylation at
cg26949694 in maternal blood but higher methylation in
placenta. Opposing directions were also observed at a
third CpG site, cg09492354; however, the low absolute
level of methylation at that site (4–5%) warrants caution
in its interpretation.
Methylation at several CpG sites (cord blood
cg16257091 and cg09492354; maternal blood
cg04106006 and cg06684850; placenta cg25962210 and
cg09492354) was associated with both stressor types in
the same tissue. Post hoc analyses comparing a one-
stressor predictor model with a two-stressor predictor
model revealed no improvement in model fit with the
two-stressor model (data not shown). This indicated that
associations observed across stressors were due to
shared variance among the two stressor types.
For the sodium bisulfite sequencing data specifically
targeting the exon 4 promotor in placental tissue, an
initial set of 9 of the 24 placentas were randomly
selected for sequencing. Across an average of 20
clones (range 18–22) per CpG site, methylation levels
were uniformly low in placental tissue (M = .003, SD
= .003). An additional 10 samples were sequenced
with no substantial change in overall mean methyla-
tion levels (M = .003, SD = .004). Of the 19 CpG sites
sequenced, nine showed any degree of variation, and
the remaining 11 sites were uniformly unmethylated
in all clones (see Additional file 1: Table S2). Targeted
bisulfite sequencing was discontinued for the
remaining five samples as it was deemed unlikely that
meaningful statistical analyses could be computed
with the limited variability that was observed in
methylation levels at this region.
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Table 1 Association estimates of stress exposures and methylation of CpG sites using beta regression








cg24249411 Venous 27744760 Intergenic 1 CTCFe –3.86 .02 .09 .22 .14 .07
cg162570911 Venous 27743580 Core promoter 2 GATA1f –3.07 .05 .15 .17 .14 .15
cg162570911 Placenta 27743580 Core promoter 2 GATA1f 2.08 .02 .27 .18 .29 .51
cg162570911 Cord 27743580 Core promoter 2 GATA1f 4.82 .02 .27 .21 .19 .10
cg07704699 Cord 27742833 Intragenic 2 Tfcp2l1f –2.93 .01 .27 .25 .22 .19
cg04106006 Venous 27742455 Proximal promoter/
intragenic
2 n/a –1.92 .03 .11 .19 .36 .23
cg10635145 Placenta 27742436 Proximal promoter/
intragenic
2 n/a 1.93 .03 .28 .19 .71 .30
cg06684850 Venous 27742369 Proximal promoter/
intragenic
2 N-Mycd, f, Mycd, AhRd, Arntd,
HIF-1d, USF2f
–3.73 .05 .15 .16 .11 .12
cg12448003 Venous 27742366 Proximal promoter/
intragenic
2 N-Mycd,f, Mycd, AhRd, Arntd,
HIF-1d, USF1d, USF2d,f,
BHLHB2f
–18.16 .01 .09 .26 .03 .02
cg25412831 Venous 27742138 Intragenic 3 n/a –5.61 .03 .17 .18 .09 .10
cg26949694 Venous 27742061 Intragenic 3 CTCFe, Tfcp2l1f –3.13 .02 .09 .23 .18 .16
cg17413943 Cord 27739827 Intragenic 4 Tfcp2l1f –8.15 .003 .18 .33 .08 .05
cg11806762 Venous 27732958 Intragenic 4 n/a 7.46 .002 .05 .34 .91 .10
cg268407702 Placenta 27723291 Proximal promoter/
intragenic
4 CTCFe, Pol2e, POU3F2g, STAT5Ag –11.97 .03 .28 .21 .04 .04
cg15914769 Cord 27722775 Intragenic 5 n/a 17.97 .03 .28 .17 .03 .02
cg10558494 Placenta 27721280 Proximal promoter/
intragenic
8 n/a 5.27 .01 .12 .17 .09 .25
cg15313332 Placenta 27721270 Proximal promoter/
intragenic
8 n/a 7.14 .002 .06 .22 .07 .21
cg25962210 Placenta 27721223 Core promoter/
intragenic
8 Esrrbf 9.61 .001 .06 .30 .06 .10
cg27193031 Placenta 27721088 Intragenic 9 Esrrbf, Tfcp2l1f 4.48 .05 .38 .12 .09 .16
cg09492354 Placenta 27720710 Intragenic 9 CTCFe, Pol2-4H8e –11.32 .02 .27 .20 .04 .02
cg09492354 Cord 27720710 Intragenic 9 CTCFe, Pol2-4H8e 9.46 .03 .28 .19 .05 .02
cg20108357 Cord 27718979 Intragenic 9 n/a 1.74 .05 .42 .15 .33 .21
cg05189570 Venous 27680481 Intragenic 11 n/a 4.75 .02 .09 .23 .89 .10
Chronic stress
cg162570911 Cord 27743580 Core promoter 2 GATA1f 5.80 .01 .19 .26 .11 .10
cg012256983 Cord 27742355 Proximal promoter/
intragenic
2 Spl1f 6.70 .05 .32 .15 .06 .09
cg04106006 Venous 27742454 Proximal promoter/
intragenic
2 n/a –1.88 .03 .85 .19 .39 .23
cg06684850 Venous 27742369 Proximal promoter/
intragenic
2 N-Mycd,f, Mycd, AhRd, Arntd,
HIF-1d, USF2f
–4.28 .02 .85 .21 .11 .12
cg26949694 Placenta 27742061 Intragenic 3 CTCFe, Tfcp2l1f 1.70 .05 .42 .15 .34 .54
cg25962210 Placenta 27721223 Core promoter/
intragenic
8 Esrrbf 8.15 .02 .42 .20 .06 .10
cg09492354 Placenta 27720710 Intragenic 9 CTCFe, Pol2-4H8e –10.78 .04 .42 .17 .04 .02
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Discussion
This study reports for the first time a significant associ-
ation of prenatal maternal traumatic stress exposure
with BDNF methylation in humans. Although only 47%
of the total CpG sites assayed were situated near puta-
tive TFBs, a majority (66%) of the significant sites were
in putative TFB regions. This finding is consistent with
another study that similarly reported an over-
representation of significant associations at TFB sites
when examining links between BDNF methylation and
history of childhood maltreatment among adult psychi-
atric patients [45].
Previously, we reported that war traumas had stron-
ger associations than chronic stress with methylation
of genes regulating the HPA axis [57]. Here, we add
to the literature on stress and epigenetics by showing
that more severe war traumas also are more strongly
related than chronic stress to methylation in a key
gene regulating neuronal and placental development.
This was evident in that all but one of the associa-
tions that survived multiple test correction at mode-
rate confidence using FDR-adjusted q values were
with war trauma. Stress associations with the HPA
genes and BDNF differed, however, in one potentially
interesting way. For the HPA genes, unique, additive
effects of chronic stress and war trauma were ob-
served when both stressors were included in a single
statistical model for those sites at which methylation
was associated with both types of stress. In contrast,
comparison of a one-stressor to a two-stressor model
Table 1 Association estimates of stress exposures and methylation of CpG sites using beta regression (Continued)
cg09492354 Cord 27720710 Intragenic 9 CTCFe, Pol2-4H8e 9.34 .05 .32 .15 .05 .02
cg15014679 Cord 27695210 Intragenic 10 n/a 5.56 .05 .32 .13 .91 .13
cg07238832 Cord 27681475 Intragenic 11 n/a 4.33 .04 .32 .17 .89 .13
Note: Underlined CpGs are significant across tissue. Italicized CpGs are significant across stressor type. Bolded lines have q value <.25. Due to potential error in
array data at the extremes of the beta distribution, CpG sites with absolute (mean) methylation <5% or >95% should be interpreted with caution. R2 values
indicate percent variance explained (after controlling for infant sex in cord blood and placenta)
n/a not available
aMultiple regions are indicated if differing according to BDNF transcript
bPutative TFBs were identified for purposes of this study via in silico modeling or molecular assay not specific to tissue source
cRegres coeff refers to the regression coefficient from beta regressions
dTFB identified via MotifMap
eTFB identified via Encode
fTFB identified via PhysBinder (avg precision)
gTFB identified via HMR Conservation
1Smith et al. [47]
2Thaler et al. [45]; Fuchikami et al. [77]; Martinowich et al. [76]; Dennis et al. [75]
3Weder et al. [46]
Fig. 1 Schematic representation of human BDNF gene, depicted from the NCBI reference number NG_011794.1 [103]. Significant CpG sites are
shown relative to intronic/exonic regions, HMR conserved TFBs, and putative TFB sites identified in Physbinder and MotifMap. Gray boxes
represent exons. Exons on different splice variants are indicated by lowercase letters and the exon numbers proposed by Pruunsild et al. [10] are
in roman numerals
Kertes et al. Clinical Epigenetics  (2017) 9:68 Page 5 of 12
for BDNF methylation indicated that chronic stress
did not add additional explanatory value above and
beyond the stronger associations observed for war
trauma for the sites at which methylation was asso-
ciated with both stressors.
The observation that war traumas rather than chronic
stress carried the bulk of the significant effects is note-
worthy. A hallmark principle in research on the biology
of stress is that biological effects are more likely to be
detected for stressors that have a high degree of uncon-
trollability and unpredictability [60]. The war trauma
index assessed in this study included such experiences
as being kidnapped, raped, having family members
killed, and being a refugee, which are arguably more se-
vere, unpredictable, and uncontrollable than the chronic
socioeconomic and socioemotional stressors captured by
the chronic stress index. Indeed, other studies of more
mild prenatal stress have not shown notable associations
with offspring methylation, at least when tested in cord
blood [61]. Despite detecting some links with chronic
stress, the preponderance of findings suggest broader
impacts of more severe war traumas on DNA
methylation.
Extensive evidence points to tissue specificity in DNA
methylation patterns (e.g., [62–65]). However, BDNF
methylation has revealed an especially complex pattern
of influences. In rodents, the same experimental stressor
may differentially impact BDNF methylation, in terms of
the significance and direction of effect, depending on
whether the stressor occurs early in life vs. adulthood,
the age at testing, the specific tissue source, and the
BDNF loci targeted [38, 40, 41, 59]. Such complexity is
also expected in peripheral tissues and in the prenatal
period, as BDNF serves multiple critical roles for pla-
cental and fetal development that differ from its roles
in the mature brain. Here, we document the links of
extreme stress with methylation in three tissues col-
lected at the time of birth: maternal blood, placental
tissue, and umbilical cord blood. The results showed
high tissue specificity. This is in line with the life
cycle model of stress positing that stress effects differ
by phase of the life course [66], developmental
models of health and disease proposing high fetal
sensitivity to intrauterine environmental cues [67],
and tissue and developmental specificity of mamma-
lian DNA methylation patterns.
In maternal blood, most of the significant CpG sites
were located upstream of exons 1 through 4, where
multiple splicing sites produce BDNF isoforms. In the
intergenic region upstream of exon 1, cg24249411 was
associated with war trauma after FDR correction. This
CpG site was situated near a putative peak point
position of CTCF binding, which regulates chromatin
structure and defines active DNA boundaries to promote
or repress gene transcription [68]. In the core promotor
of exon 2, cg12257091 was significantly associated with
war trauma at FDR-corrected significance. This CpG
was located at the putative binding site for GATA1, a
transcriptional activator or repressor believed to
promote erythroid development. Methylation at this site
in adult peripheral blood has previously been identified
as associated with post-traumatic stress disorder [47].
Three additional CpG sites (cg04106006, cg0668450, and
cg12448003) located in the proximal promotor or
intragenic region upstream of exon 2 were significantly
associated with maternal stress at FDR-corrected sig-
nificance levels.
Observed associations of maternal stress with methyla-
tion at cg0668450 and cg12448003 are theoretically
compelling because they are situated at multiple TFBs.
cg0668450 was located in a region containing putative
sites for six transcription factors, including N-Myc, Myc,
AhR, Arnt, HIF-1, USF2, and cg12448003 is at putative
binding sites for eight TFBs, including N-Myc, Myc,
AhR, Arnt, HIF-1, USF1, USF2, and BHLHB2. Several of
these transcription factors have known effects on BDNF
expression or neural function, specifically, BHLHB2,
USF2, and MYCN (Fig. 1 and Additional file 1: Table
S1). BHLHB2 is known to control BDNF promoter activ-
ity and neuronal excitability [69], and USF2 acts as a
transcriptional activator at a number of activity-
regulated promoters [70]. MYCN is highly expressed in
brain and critical for normal brain development [71].
Recently, it has been found that MYCN co-localizes and
interacts with methyl-CpG-binding protein 2 (MeCP2)
[72]. Of note, cg12448003 is within a “TCACGTGC”
sequence. This is a cyclic adenosine monophosphate
(cAMP)-responsive element (CRE)-binding protein re-
sponse element “TGACGTCA”-like sequence with base
substitutions at −2, −7, and −8 positions. This is poten-
tially meaningful because it has already been observed that
CRE-like elements, with base substitutions, serve as CREB
binding sites [73] and binding of cAMP at a CRE plays a
central role in neural activity-dependent BDNF gene ex-
pression by enhancing transcriptional activity [9, 11]. In
addition, cg26949694, associated with war trauma in ma-
ternal blood, was located in the intragenic region up-
stream of exon 3 at the putative binding site for Tfcp2l1,
which suppresses DNA transcription, and near the peak
point of a putative binding region for CTCF. Collect-
ively, the presence of a binding site for cAMP as well
as multiple transcription factors, including those
known to specifically affect BDNF gene expression or
neural function, suggests potential functional conse-
quences of war trauma on BDNF. Even for those
CpG sites at which putative TFBs were identified, the
functional role of transcription factors at the putative
binding regions on gene activity and DNA
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methylation in these tissues requires experimental val-
idation and further investigation.
Methylation at three additional CpG sites was signifi-
cantly associated in maternal blood with war trauma at
FDR-corrected significance: cg25412831, cg11806762,
and cg05189570. As these CpG sites were not at docu-
mented TFBs, the functional relevance of these findings
is unknown.
With respect to findings in placental tissue, war
trauma was associated after FDR correction with methy-
lation at three CpG sites upstream of exon 8.
cg25962210, associated with both war trauma and
chronic stress, is located in the core promotor or intra-
genic region of exon 8, depending on splice variant. This
CpG site is situated at a putative binding site for Esrrb,
which is involved in both stress regulation and placental
development [74]. Also significantly associated with war
trauma were cg10558494 and cg15313332, both situated
at the proximal promotor (or intragenic) region of exon
8 with no known TFBs. Maternal stressors were
nominally associated with additional CpG sites in the
intragenic region upstream of exons 3, 4, and 9. They in-
cluded cg26949694, situated near the peak point position
of a putative CTCF binding region and at the putative
binding site of Tfcp2l1, cg27193031, situated at Esrrb
and Tfcp2l1 putative binding sites, and cg09492354, situ-
ated near the peak point positions of the putative bind-
ing regions for CTCF and Pol2-4H8, the largest subunit
of polymerase II. Also significant in placental tissue was
cg26840770, which was situated near the peak points of
the CTCF and POL2 putative binding regions and at the
HMR conserved binding sites for POU3F2 and STAT5A.
POU3F2 is involved in neuronal differentiation and
enhances the activation of corticotrophin-releasing
hormone regulated genes. STAT5A is a transcriptional
activator that mediates the responses of many cell li-
gands. cg26840770 methylation has been previously
identified in studies of brain function in rodents [75, 76]
and stress-related mental disorders in humans [45, 77].
In cord blood, maternal stress predicted methylation
at five sites located in TFB regions, the majority of them
upstream of exon 2. Among them was cg16257091,
located in the core promotor of exon 2, which was
nominally associated with war trauma and significantly
associated after FDR correction with chronic stress. This
CpG site was situated at the putative binding site of
GATA1, which regulates the switch of fetal hemoglobin
to adult hemoglobin. Also upstream of exon 2,
cg07704699 methylation was associated with war
trauma. This CpG site was situated at the putative bin-
ding sites for Tfcp2l1. cg01225698, located in the prox-
imal promotor or the intragenic region depending on
splice variant, was situated at a putative binding site for
Spl1, which reduces DNA binding. Methylation at this
site has previously been associated with child maltreat-
ment [46]. Another noteworthy finding in cord blood
was the significant association after FDR correction of
war trauma with cg17413943, located upstream of exon
4 in the intragenic region and at a Tfcp2l1 putative
binding site. cg09492354, located in the intragenic re-
gion upstream of exon 9, was nominally associated with
war trauma and chronic stress. Although caution is
warranted in interpreting cg09492354 given the very low
absolute methylation level, this CpG is in a genomic re-
gion near the peak point position of the putative binding
regions for CTCF and Pol2-4H8.
The sequencing data of the exon 4 promotor region
revealed that the region was almost entirely unmethy-
lated in placental tissue. Although the low methylation
levels precluded analyzing DNA methylation variation in
relation to maternal stress, the low levels in themselves
are noteworthy. The region sequenced encompasses a
transcription start site as well as a cAMP response elem-
ent. Moreover, this exon contains binding sites for
MeCP2, known to suppress gene transcription, and
CREB, an upstream transcriptional activator of BDNF
[11, 78]. It is believed that cAMP binding plays a central
role in neural activity-dependent BDNF gene expression
by enhancing transcriptional activity [9, 11]. In animal
models, prenatal stress exposure impacts methylation in
this region among offspring in the amygdala and hippo-
campus [35]. Given the important role that BDNF plays
in placental and fetal development, it is notable that this
important regulatory region was nearly entirely unmethy-
lated in placenta and therefore fully accessible to tran-
scription factors. It also suggests that transcription factors
that bind to this region may play an important role in
BDNF regulation in placenta.
A limitation of this study is the relatively small
sample size. We were, however, able to detect signifi-
cant associations even with FDR correction, and our
sample size is comparable to other recent human
methylation studies (N = 19–36), including studies
examining the effects of psychosocial stress [79–83].
The small sample size precluded testing potential as-
sociations of stress and methylation for newborn boys
and girls separately. Some rodent studies examining
BDNF methylation have observed sex-specific effects
in brain (e.g., [37, 40]). However, a recent human
study documenting an association of prenatal mater-
nal depressive symptoms with BDNF methylation in
both male and female infants suggests no sex differ-
ence, at least in human peripheral tissue [51].
Conclusions
BDNF transcripts are heterogeneously expressed in brain
regions and in the periphery, the complexity of which
has yet to be fully understood [3, 10]. Because of this
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heterogeneity, we do not assume that BDNF methyla-
tion in peripheral tissues is the same as in a particu-
lar brain region. Nevertheless, examining BDNF
methylation in these tissues is relevant for prenatal
development as BDNF plays a role in placental and
fetal growth [7] and BDNF protein levels in the per-
iphery are associated with birth outcomes [23–25].
Recent research has documented several types of pre-
natal exposures, including air pollution and nicotine
use, are associated with placental BDNF methylation
[84, 85]. Our study is the first in humans to examine
BDNF methylation patterns in relation to prenatal
exposure to maternal stress in three tissues simultan-
eously and the first in any mammalian species to re-
port prenatal stress—BDNF methylation associations
in placental tissue.
The findings from this research add to the growing body
of evidence highlighting the importance of considering
epigenetic effects when examining the impacts of trauma
and stress, not only for adults but also for offspring ex-
posed via effects transmitted before birth. This knowledge
highlights the potential intergenerational impact of




Participants were 24 mothers and their newborns living
in the eastern Democratic Republic of Congo, a region
with long-term military and civilian conflict and a his-
tory of severe violence against women. Participants were
recruited from HEAL Africa hospital, Goma. Any
mother who gave birth at the hospital during the period
of data collection was eligible for inclusion. Participation
was voluntary and confidential.
Informed consent was obtained under approval from
Western IRB, the University of Goma, and an ethical re-
view committee at HEAL Africa hospital, Goma. During
oral consent, mothers were provided with a detailed ex-
planation of the project and the possible uses of results
and encouraged to ask questions about the study and its
objectives.
Mean maternal age was 26.9 years (SD = 5.6), and 29%
of mothers were primiparous (N children range = 1–9).
The majority of women were married (79%) and co-
habitating with the father of their child (75%). All
mothers self-reported as non-smokers. The majority of
births were vaginal deliveries (83%). Fifty-four percent of
infants were male.
Procedure
Umbilical cord blood, maternal venous blood, and
placental tissue from the largest fetal cotyledon were ob-
tained shortly after birth. A cord blood sample was not
obtained from one newborn, yielding 23 cord blood, 24
placenta, and 24 maternal blood samples.
To obtain maternal report of stress exposure, mothers
were interviewed within one day after birth regarding
general health, reproductive history, chronic socioeco-
nomic and socioemotional stress, and war-related
traumas using culturally sensitive, semi-structured
ethnographic interviews [86]. Interviews were conducted
in the Congolese dialect of Swahili and followed an oral
history format designed to facilitate rapport and
emphasize open dialogue between the participant and
interviewer. Questions assessed stressors relevant to this
cultural setting, while also covering constructs measured
in standardized stress and trauma inventories [87, 88].
Interviews were transcribed and coded for the pres-
ence or absence of 32 stressors. From this initial pool of
items, two composite scales were generated that
reflected Chronic Stress (19 items) and War Trauma (10
items). The construct and content of the stressor scales
has previously been described in detail [57]. Briefly,
chronic stress included items such as an unhappy mar-
riage and difficulty paying bills. War traumas reflected
experiences as a refugee, war-related rape, and exposure
to armed conflict. The content of these two scales was
determined using factor analysis. Two items (in-law
stress and co-wives) that did not load with the other
stress items were dropped, as was a third item pertaining
to rape that showed redundancy with another question.
Total scores were computed as an additive count of the
number of chronic stress and war trauma items
endorsed. There was wide variability in the presence and
number of stressors reported. Fifty-five percent of
mothers reported experiencing at least one war trauma
(M = 1.58, SD = 2.21; range = 0–8). Of those, 31%
reported one event, and an equal proportion of 23%
reported two, three, or four or more events. The most
commonly reported events were having been raped and/
or a refugee as a result of war. Chronic stress also showed
wide variability (M = 6.54, SD = 6.32; range = 0–18), with
33% reporting few (0–1) stressors and the remainder
reporting higher levels of chronic stress. Internal
consistency of the final scales was high with Cronbach’s
α > .80 for each. As we have reported previously [57],
the correlation between the scales was high (r = .74,
p < .001).
Epigenotyping
Genomic DNA was extracted from all tissues using
Qiagen QIAamp DNA Midi Kits (Qiagen, Valencia, CA)
and treated with sodium bisulfite. Samples (500 ng) were
processed on Illumina HumanMethylation450 Bead-
Chips at the University of Miami Hussman Institute for
Human Genomics in Miami, FL, with output processed
through Illumina’s GenomeStudio V2011.1 Methylation
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Module v1.9.0. The chip epigenotyping method enables
assessment of CpG sites distributed broadly across the
gene region. Methylation was indexed via average beta
estimates. Quality control was evaluated using detection
p value such that a value below the detection p value
threshold indicated successful detection. In this study,
any probe with a p value >.01 in any one sample was
eliminated in all tissues. Using data from the 1000
Genomes Project, AFR population [89], we removed
probes containing any of the following variation: (1) an
observed variant, at any frequency, at the targeted CpG
site, (2) an observed variant with an allele frequency
≥5% in the probe sequence, and (3) three or more vari-
ants at any frequency within the probe sequence. Using
public data from Chen et al. (2011), probes that cross-
hybridize with unspecific genomic targets were removed.
After data filtering, type I and type II probes were nor-
malized using the BMIQ package [90] as implemented
in R [91]. Output from a total of 67 probes from across
the BDNF gene were generated.
Several publicly available bioinformatics resources
were used to identify putative TFBs. UCSC genome
browser [92] was used to find HMR conserved TFBs and
the proximity of putative ENCODE TFB regions to the
CpG sites assayed via chip sequencing. The presence of
putative TFBs flanking a given CpG site was further
assessed using PhysBinder [93], with the threshold level
set to average precision, and MotifMap [94]. See
Additional file 1: Table S1 for the specific locations of
putative transcription factor binding regions.
Sodium bisulfite sequencing
A 376-bp region containing 19 CpG sites from the exon 4
promoter (Additional file 1: Figure S1) in placenta was
amplified in two rounds of polymerase chain reaction.
Fragments were amplified using HotStarTaq Polymerase
(Qiagen, Valencia, CA) and the following primers: forward
TTTTTGGTGTTYGGTATGTATTTTTTTTGTTTTG-
TAG and reverse AAAAACATACAATACCCTAAAAC.
The PCR reaction (25 μl) was loaded on an agarose gel
and DNA was extracted with QIAquick Gel Extraction Kit
(Qiagen, Valencia, CA). The purified PCR fragments were
cloned using CloneJET PCR cloning kit (Thermo Scien-
tific, Pittsburgh, PA) according to the manufacturer’s in-
structions. An average of 20 clones per sample was
sequenced at Eurofins Genomics (Huntsville, AL). The
output was processed using Sequencher 5.2 (Gene Codes
Corp., Ann Arbor, MI).
Statistical analysis
Statistical analyses were conducted using SPSS v22.0 and
R v3.1.2. As a quality control step, principle components
analysis of methylation from the 450K array data using
all three tissue sources was run to ensure that placental
and blood samples were not cross-contaminated before
proceeding with primary analyses. As the dependent
variable, methylation, lay on a beta distribution of 0
(fully unmethylated) to 1 (fully methylated), beta regres-
sion was used to test associations of the individual CpG
sites with chronic stress and war trauma using the
betareg package for R [95]. Infant sex was included as a
covariate in analyses of cord blood and placenta [96]. To
address multiple testing, q values were computed to esti-
mate false discovery rate (FDR) with q < .25 demonstrat-
ing “moderate confidence” of statistically significant
findings [97].
We intentionally did not contrast methylation levels in
this population to control groups generated from
Western populations or other geographic areas as a
non-stressed comparison group. Rather, a wide range of
stressors was reported among the women in this study,
with some reporting few stressors. This provided suffi-
cient natural variation to examine the associations of
maternal stress and methylation within a population of
women controlling for geographic and cultural context.
Given the novelty of examining BDNF methylation in
three tissues simultaneously, and the fact that p values
and other statistics derived from them are in themselves
arbitrary thresholds which may overlook many variants
with smaller but real effects [98–100], a two-pronged
approach was employed for identifying loci of interest
for future research: (a) those that meet strict statistical
significance criteria based on both p < .05 and q < .25, re-
gardless of what, if anything, is known about those sites,
and (b) those that meet the unadjusted p < .05 level of
significance but are potentially important based on being
located at putative transcription factor binding sites and
thus of interest for future studies examining BDNF
expression [45, 57] or prior evidence of association, as
has been recommended for and used in genetic studies
[46, 100–102].
Additional file
Additional file 1: Table S1. Position of significant CpG sites in relation
to putative transcription factors, according to source. Table S2. CpG sites
identified via bisulfite sequencing with their genomic locations and
positions.Figure S1. Genomic region of Chr11:27722975-27723350
(GRCh37/hg19) representing the cloned sequence in placental tissue.
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